Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 19, 2026, 11:13 am
Author: Getaka|Social: XLinkedIn

Genesys International Corporation Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 19, 2026, 11:13 am

Market Cap 1,345 Cr.
Current Price 322
Intrinsic Value₹574.12
High / Low 799/285
Stock P/E31.1
Book Value 164
Dividend Yield0.00 %
ROCE15.0 %
ROE10.8 %
Face Value 5.00
PEG Ratio1.12

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Genesys International Corporation Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Visesh Infotecnics Ltd 125 Cr. 0.33 / 1.110.00 %2.21 %2.23 % 1.00
Mudunuru Ltd 41.1 Cr. 13.0 21.0/4.43 0.200.00 %27.0 %90.7 % 2.00
Naapbooks Ltd 118 Cr. 109 194/98.118.0 36.40.00 %23.6 %17.1 % 10.0
IB Infotech Enterprises Ltd 61.5 Cr. 480 480/14038.4 26.70.21 %38.5 %35.4 % 10.0
Hit Kit Global Solutions Ltd 15.2 Cr. 2.83 2.83/0.91 2.240.00 %2.14 %2.15 % 2.00
Industry Average17,951.84 Cr484.64110.75121.920.66%14.90%21.00%6.84

All Competitor Stocks of Genesys International Corporation Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 37544735335971567289947177
Expenses 26353029252935354347444147
Operating Profit 111916683136202943503030
OPM % 29%36%35%17%23%52%51%37%41%48%53%42%39%
Other Income 2211130112014
Interest 1011111123333
Depreciation 991111111111121216151516
Profit before tax 3126-5-3212491626321215
Tax % 6%33%64%4%21%26%39%40%32%21%40%43%20%
Net Profit 382-5-316155112119712
EPS in Rs 1.302.130.57-1.41-0.874.193.761.362.835.204.761.712.88

Last Updated: January 1, 2026, 5:04 pm

Below is a detailed analysis of the quarterly data for Genesys International Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 77.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Jun 2025) to 77.00 Cr., marking an increase of 6.00 Cr..
  • For Expenses, as of Sep 2025, the value is 47.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 41.00 Cr. (Jun 2025) to 47.00 Cr., marking an increase of 6.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 30.00 Cr..
  • For OPM %, as of Sep 2025, the value is 39.00%. The value appears to be declining and may need further review. It has decreased from 42.00% (Jun 2025) to 39.00%, marking a decrease of 3.00%.
  • For Other Income, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 3.00 Cr..
  • For Interest, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 3.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 1.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Jun 2025) to 15.00 Cr., marking an increase of 3.00 Cr..
  • For Tax %, as of Sep 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 43.00% (Jun 2025) to 20.00%, marking a decrease of 23.00%.
  • For Net Profit, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 5.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 2.88. The value appears strong and on an upward trend. It has increased from 1.71 (Jun 2025) to 2.88, marking an increase of 1.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:20 am

MetricMar 2011Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 9560476411411511280120181198311331
Expenses 424740487896988192122117168179
Operating Profit 5313716361913-2285981143152
OPM % 56%21%16%25%32%17%12%-2%23%32%41%46%46%
Other Income -1263434-30-426547
Interest 022223343351012
Depreciation 78713141921191937445562
Profit before tax 45555240-7-54-3625378385
Tax % -1%11%6%-41%28%1,108%-23%-5%11%40%42%32%
Net Profit 4642617-4-5-52-4015225659
EPS in Rs 15.421.430.732.115.501.730.61-13.754.285.055.5814.1214.55
Dividend Payout % 8%9%17%6%2%7%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-50.00%200.00%183.33%-123.53%-25.00%-940.00%23.08%137.50%46.67%154.55%
Change in YoY Net Profit Growth (%)0.00%250.00%-16.67%-306.86%98.53%-915.00%963.08%114.42%-90.83%107.88%

Genesys International Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:18%
5 Years:23%
3 Years:38%
TTM:49%
Compounded Profit Growth
10 Years:29%
5 Years:98%
3 Years:-3%
TTM:77%
Stock Price CAGR
10 Years:29%
5 Years:63%
3 Years:1%
1 Year:-25%
Return on Equity
10 Years:6%
5 Years:8%
3 Years:7%
Last Year:11%

Last Updated: September 5, 2025, 4:40 am

Balance Sheet

Last Updated: December 4, 2025, 1:16 am

MonthMar 2011Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 15151515151616161619202021
Reserves 126193195152209208197158189387469536662
Borrowings 212142224261614263960122147
Other Liabilities 23253713513613413611788618610090
Total Liabilities 165244262324385383365304319506635778920
Fixed Assets 462122179217208203194138157156128265
CWIP 0000000019651131564
Investments 8122156251111158651000
Other Assets 11110184120157165147102156232366495652
Total Assets 165244262324385383365304319506635778920

Below is a detailed analysis of the balance sheet data for Genesys International Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 1.00 Cr..
  • For Reserves, as of Sep 2025, the value is 662.00 Cr.. The value appears strong and on an upward trend. It has increased from 536.00 Cr. (Mar 2025) to 662.00 Cr., marking an increase of 126.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 122.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 25.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 90.00 Cr.. The value appears to be improving (decreasing). It has decreased from 100.00 Cr. (Mar 2025) to 90.00 Cr., marking a decrease of 10.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 920.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 778.00 Cr. (Mar 2025) to 920.00 Cr., marking an increase of 142.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 128.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 137.00 Cr..
  • For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 156.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 152.00 Cr..
  • For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 652.00 Cr.. The value appears strong and on an upward trend. It has increased from 495.00 Cr. (Mar 2025) to 652.00 Cr., marking an increase of 157.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 920.00 Cr.. The value appears strong and on an upward trend. It has increased from 778.00 Cr. (Mar 2025) to 920.00 Cr., marking an increase of 142.00 Cr..

Notably, the Reserves (662.00 Cr.) exceed the Borrowings (147.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2011Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 34145-317-23311928-3519-53
Cash from Investing Activity + 5-4-4213-37-17-15-12-20-188-80-18
Cash from Financing Activity + -23-24387-14-8122157150
Net Cash Flow 37-011417-342-120-911-20

Free Cash Flow

MonthMar 2011Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow51.001.00-7.00-6.0012.00-7.00-3.00-16.002.0020.0021.0021.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2011Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 120343219132134186155148150168263261
Inventory Days
Days Payable
Cash Conversion Cycle 120343219132134186155148150168263261
Working Capital Days 1723261721059921522312682212269291
ROCE %41%3%3%8%1%-1%-7%4%7%8%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters 40.60%39.70%39.69%39.65%39.62%37.91%37.85%37.33%33.14%33.08%31.63%31.55%
FIIs 6.63%6.50%6.33%6.31%4.68%8.55%8.22%7.97%7.77%5.11%4.84%4.69%
DIIs 0.01%0.01%0.01%0.01%0.06%0.10%0.07%0.19%0.93%0.68%1.51%1.47%
Public 52.76%53.80%53.98%54.04%55.66%53.43%53.85%54.49%58.15%61.13%62.00%62.27%
No. of Shareholders 7,4017,4228,95210,05112,90215,16818,89722,90536,53638,24344,24745,192

Shareholding Pattern Chart

No. of Shareholders

Genesys International Corporation Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 14.175.785.444.28-13.77
Diluted EPS (Rs.) 14.065.745.294.28-13.34
Cash EPS (Rs.) 27.9216.7213.81-6.55-10.57
Book Value[Excl.RevalReserv]/Share (Rs.) 139.53123.71107.9375.2181.64
Book Value[Incl.RevalReserv]/Share (Rs.) 139.53123.71107.9375.2181.64
Revenue From Operations / Share (Rs.) 78.1450.1447.9738.1425.48
PBDIT / Share (Rs.) 36.8021.6417.189.83-0.49
PBIT / Share (Rs.) 22.9810.397.333.74-6.51
PBT / Share (Rs.) 20.779.406.62-11.44-17.43
Net Profit / Share (Rs.) 14.105.473.95-12.65-16.59
NP After MI And SOA / Share (Rs.) 14.135.585.054.28-13.75
PBDIT Margin (%) 47.0943.1635.8125.78-1.95
PBIT Margin (%) 29.4020.7215.279.79-25.53
PBT Margin (%) 26.5818.7513.79-29.98-68.43
Net Profit Margin (%) 18.0310.908.24-33.17-65.09
NP After MI And SOA Margin (%) 18.0711.1310.5311.21-53.96
Return on Networth / Equity (%) 10.124.514.706.54-24.77
Return on Capital Employeed (%) 15.537.816.334.76-7.59
Return On Assets (%) 7.223.473.774.17-14.11
Long Term Debt / Equity (X) 0.020.040.040.010.00
Total Debt / Equity (X) 0.190.100.070.090.03
Asset Turnover Ratio (%) 0.440.340.430.410.23
Current Ratio (X) 2.413.043.521.732.13
Quick Ratio (X) 2.413.043.521.732.13
Interest Coverage Ratio (X) 16.6821.8924.3312.45-0.53
Interest Coverage Ratio (Post Tax) (X) 7.396.536.603.19-6.06
Enterprise Value (Cr.) 2956.652312.971258.231817.61404.10
EV / Net Operating Revenue (X) 9.5111.676.9515.195.08
EV / EBITDA (X) 20.1827.0319.4058.93-260.36
MarketCap / Net Operating Revenue (X) 9.2111.786.8614.954.02
Price / BV (X) 5.164.783.068.731.84
Price / Net Operating Revenue (X) 9.2111.786.8614.954.02
EarningsYield 0.010.010.010.01-0.13

After reviewing the key financial ratios for Genesys International Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 14.17. This value is within the healthy range. It has increased from 5.78 (Mar 24) to 14.17, marking an increase of 8.39.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has increased from 5.74 (Mar 24) to 14.06, marking an increase of 8.32.
  • For Cash EPS (Rs.), as of Mar 25, the value is 27.92. This value is within the healthy range. It has increased from 16.72 (Mar 24) to 27.92, marking an increase of 11.20.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 139.53. It has increased from 123.71 (Mar 24) to 139.53, marking an increase of 15.82.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 139.53. It has increased from 123.71 (Mar 24) to 139.53, marking an increase of 15.82.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 78.14. It has increased from 50.14 (Mar 24) to 78.14, marking an increase of 28.00.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 36.80. This value is within the healthy range. It has increased from 21.64 (Mar 24) to 36.80, marking an increase of 15.16.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 22.98. This value is within the healthy range. It has increased from 10.39 (Mar 24) to 22.98, marking an increase of 12.59.
  • For PBT / Share (Rs.), as of Mar 25, the value is 20.77. This value is within the healthy range. It has increased from 9.40 (Mar 24) to 20.77, marking an increase of 11.37.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 14.10. This value is within the healthy range. It has increased from 5.47 (Mar 24) to 14.10, marking an increase of 8.63.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 14.13. This value is within the healthy range. It has increased from 5.58 (Mar 24) to 14.13, marking an increase of 8.55.
  • For PBDIT Margin (%), as of Mar 25, the value is 47.09. This value is within the healthy range. It has increased from 43.16 (Mar 24) to 47.09, marking an increase of 3.93.
  • For PBIT Margin (%), as of Mar 25, the value is 29.40. This value exceeds the healthy maximum of 20. It has increased from 20.72 (Mar 24) to 29.40, marking an increase of 8.68.
  • For PBT Margin (%), as of Mar 25, the value is 26.58. This value is within the healthy range. It has increased from 18.75 (Mar 24) to 26.58, marking an increase of 7.83.
  • For Net Profit Margin (%), as of Mar 25, the value is 18.03. This value exceeds the healthy maximum of 10. It has increased from 10.90 (Mar 24) to 18.03, marking an increase of 7.13.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.07. This value is within the healthy range. It has increased from 11.13 (Mar 24) to 18.07, marking an increase of 6.94.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 10.12. This value is below the healthy minimum of 15. It has increased from 4.51 (Mar 24) to 10.12, marking an increase of 5.61.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 15.53. This value is within the healthy range. It has increased from 7.81 (Mar 24) to 15.53, marking an increase of 7.72.
  • For Return On Assets (%), as of Mar 25, the value is 7.22. This value is within the healthy range. It has increased from 3.47 (Mar 24) to 7.22, marking an increase of 3.75.
  • For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
  • For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.19, marking an increase of 0.09.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.44. It has increased from 0.34 (Mar 24) to 0.44, marking an increase of 0.10.
  • For Current Ratio (X), as of Mar 25, the value is 2.41. This value is within the healthy range. It has decreased from 3.04 (Mar 24) to 2.41, marking a decrease of 0.63.
  • For Quick Ratio (X), as of Mar 25, the value is 2.41. This value exceeds the healthy maximum of 2. It has decreased from 3.04 (Mar 24) to 2.41, marking a decrease of 0.63.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 16.68. This value is within the healthy range. It has decreased from 21.89 (Mar 24) to 16.68, marking a decrease of 5.21.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 7.39. This value is within the healthy range. It has increased from 6.53 (Mar 24) to 7.39, marking an increase of 0.86.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 2,956.65. It has increased from 2,312.97 (Mar 24) to 2,956.65, marking an increase of 643.68.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.51. This value exceeds the healthy maximum of 3. It has decreased from 11.67 (Mar 24) to 9.51, marking a decrease of 2.16.
  • For EV / EBITDA (X), as of Mar 25, the value is 20.18. This value exceeds the healthy maximum of 15. It has decreased from 27.03 (Mar 24) to 20.18, marking a decrease of 6.85.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.21. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 9.21, marking a decrease of 2.57.
  • For Price / BV (X), as of Mar 25, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 4.78 (Mar 24) to 5.16, marking an increase of 0.38.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.21. This value exceeds the healthy maximum of 3. It has decreased from 11.78 (Mar 24) to 9.21, marking a decrease of 2.57.
  • For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Genesys International Corporation Ltd as of February 19, 2026 is: ₹449.49

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 19, 2026, Genesys International Corporation Ltd is Undervalued by 39.59% compared to the current share price ₹322.00

Intrinsic Value of Genesys International Corporation Ltd as of February 19, 2026 is: ₹574.12

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 19, 2026, Genesys International Corporation Ltd is Undervalued by 78.30% compared to the current share price ₹322.00

Last 5 Year EPS CAGR: 27.73%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (283.15 cr) compared to borrowings (40.31 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (140.62 cr) and profit (16.69 cr) over the years.
  1. The stock has a low average ROCE of 6.83%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 191.00, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 189.92, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Genesys International Corporation Ltd:
    1. Net Profit Margin: 18.03%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 15.53% (Industry Average ROCE: 14.9%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 10.12% (Industry Average ROE: 21%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 7.39
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.41
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 31.1 (Industry average Stock P/E: 110.75)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.19
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Genesys International Corporation Ltd. is a Public Limited Listed company incorporated on 28/01/1983 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L65990MH1983PLC029197 and registration number is 029197. Currently Company is involved in the business activities of Architectural and engineering activities and related technical consultancy. Company's Total Operating Revenue is Rs. 284.43 Cr. and Equity Capital is Rs. 19.90 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
IT Consulting & Software73-A, SDF-III, SEEPZ, Mumbai Maharashtra 400096Contact not found
Management
NamePosition Held
Mr. Sajid MalikChairman & Managing Director
Ms. Bharti SinhaIndependent Director
Mr. Manish PatelIndependent Director
Mr. Ajay AggarwalIndependent Director
Mr. Omprakash HemrajaniDirector
Dr. Yogita ShuklaDirector

FAQ

What is the intrinsic value of Genesys International Corporation Ltd?

Genesys International Corporation Ltd's intrinsic value (as of 19 February 2026) is ₹574.12 which is 78.30% higher the current market price of ₹322.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,345 Cr. market cap, FY2025-2026 high/low of ₹799/285, reserves of ₹662 Cr, and liabilities of ₹920 Cr.

What is the Market Cap of Genesys International Corporation Ltd?

The Market Cap of Genesys International Corporation Ltd is 1,345 Cr..

What is the current Stock Price of Genesys International Corporation Ltd as on 19 February 2026?

The current stock price of Genesys International Corporation Ltd as on 19 February 2026 is ₹322.

What is the High / Low of Genesys International Corporation Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Genesys International Corporation Ltd stocks is ₹799/285.

What is the Stock P/E of Genesys International Corporation Ltd?

The Stock P/E of Genesys International Corporation Ltd is 31.1.

What is the Book Value of Genesys International Corporation Ltd?

The Book Value of Genesys International Corporation Ltd is 164.

What is the Dividend Yield of Genesys International Corporation Ltd?

The Dividend Yield of Genesys International Corporation Ltd is 0.00 %.

What is the ROCE of Genesys International Corporation Ltd?

The ROCE of Genesys International Corporation Ltd is 15.0 %.

What is the ROE of Genesys International Corporation Ltd?

The ROE of Genesys International Corporation Ltd is 10.8 %.

What is the Face Value of Genesys International Corporation Ltd?

The Face Value of Genesys International Corporation Ltd is 5.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Genesys International Corporation Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports